25447 Baricitinib treatment results in clinically meaningful itch reduction and enhanced quality of life in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5
Kwatra S, Forman S, Cruz A, Ball S, DeLozier A, Pierce E, Buchanan A, Sun L, Ding Y, Strober B. 25447 Baricitinib treatment results in clinically meaningful itch reduction and enhanced quality of life in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5. Journal Of The American Academy Of Dermatology 2021, 85: ab59. DOI: 10.1016/j.jaad.2021.06.260.Peer-Reviewed Original Research